Chinese regulator approves personalised cancer vaccine trial
Drug Discovery World
MARCH 30, 2023
According to GlobalData’s Pharma Intelligence Center, there are currently four personalised cancer vaccines in clinical development in China. Most of these vaccines have a subcutaneous mode of administration and are subunit vaccines, except LK101, which is dendritic cell-based mRNA vaccine.
Let's personalize your content